Skip to main content
MedPathMedPath Home
Clinical Trials/DRKS00004795
DRKS00004795
Completed
Not Applicable

Prevention of Thromboembolic Events – European Registry in Venous Thromboembolism - PREFER in VTE

Daiichi-Sankyo Europe GmbH0 sites3,544 target enrollmentMarch 15, 2013
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsMedDRA - Venous ThromboembolismI82Other venous embolism and thrombosis

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
MedDRA - Venous Thromboembolism
Sponsor
Daiichi-Sankyo Europe GmbH
Enrollment
3544
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 15, 2013
End Date
August 28, 2015
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Established acute initial or recurrent VTE
  • •In hospitals, surgical or non\-surgical wards or specialised office\-based centres
  • •Written informed consent for participation in the registry (including telephone follow\-ups)
  • •Not simultaneously participating in a double blind interventional study

Exclusion Criteria

  • •No explicit medical exclusion criteria are stated

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Not Applicable
PROTECT - Prophylaxis of ThromboEmbolism in Critical Care Trial - PROTECTCritically ill patients who require admission to the intensive care unit and need pharmacologic thromboprophylaxis
EUCTR2009-012387-13-GBMcMaster University3,650
Active, not recruiting
Phase 1
The SYMPTOMS (SYstematic elderly Medical Patients Thromboprophylaxis : efficacy on symptomatic OutcoMeS) studyVenous ThromboembolismMedDRA version: 18.0Level: LLTClassification code 10049909Term: Venous thromboembolism prophylaxisSystem Organ Class: 100000004865Therapeutic area: Not possible to specify
EUCTR2014-000311-13-FRCHRU de Brest5,030
Completed
Not Applicable
Optimising thromboembolic and stroke prevention in pharmacist-managed oral anticoagulotherapyThromboembolism and strokeCirculatory SystemStroke
ISRCTN76463647Cité de la Santé de Laval (Canada)500
Recruiting
Not Applicable
Prevention of local thromboembolic complications during continuous infusion of coagulation factor concentrates: parallel infusion of saline or heparin?Continuous infusionCoagulation factor concentratesHeparinSaline
NL-OMON23399MC utrecht42
Completed
Not Applicable
Prevention of local thromboembolic complications during continuous infusion of coagulation factor concentrates: parallel infusion of saline versus heparin and parallel infusion of saline?bleeding disorderHaemophilia10005330
NL-OMON36776niversitair Medisch Centrum Utrecht42